{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-122394","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.342495+00:00","generated_at":"2026-06-03T05:42:42.077188+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biote settles founder litigation, repurchases all 18.4M shares for ~$76.9M","bullets":["Repurchases 18.4M shares at $4.17 avg price; $32.2M paid on April 26, remainder over 3 years.","Mutual release of all claims in the Donovitz litigation; founder advisory agreement terminated.","Two-year non-compete and non-solicitation agreements with Donovitz; voting agreement signed.","CEO says settlement resolves costly litigation and multi-year repurchase will be accretive.","Financial impacts of settlement to be detailed in Q1 results on May 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-122394","json":"https://secwatch.observer/filing/0001193125-24-122394.json","markdown":"https://secwatch.observer/filing/0001193125-24-122394.md","text":"https://secwatch.observer/filing/0001193125-24-122394.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524122394/0001193125-24-122394-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524122394/d831222d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:42:42.077188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"737a50aa62179778548aba998f04fc4419d9f5b8","claim":"biote Corp. entered into Settlement Agreement with Dr. Gary S. Donovitz valued at approximately $76.9 million (effective 2024-04-23).","evidence_excerpt":"On April 23, 2024, biote Corp., a Delaware corporation (the “Company”) entered into a Settlement Agreement (the “Settlement Agreement”) with respect to its previously disclosed litigation with one of the Company’s stockholders, Dr. Gary S. Donovitz (“Donovitz”) (the “Donovitz Litigation”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524122394/0001193125-24-122394-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Dr. Gary S. Donovitz"},{"label":"Value","value":"approximately $76.9 million"},{"label":"Effective","value":"2024-04-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}